Cargando…

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea

BACKGROUND: Few post-marketing surveillance studies have examined the safety and efficacy of Rapamune® (Sirolimus) in Asian countries. This study aimed to better understand safety and efficacy of Rapamune for kidney transplant recipients in the routine clinical practice setting in Korea. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Hee Jung, Lee, Hahn-Ey, Yang, Jaeseok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090799/ https://www.ncbi.nlm.nih.gov/pubmed/30103684 http://dx.doi.org/10.1186/s12882-018-1002-6

Ejemplares similares

Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020)

Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
por: Burke, Michael Thomas, et al.
Publicado: (2017)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype
por: Carroll, Robert P., et al.
Publicado: (2013)

Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus
por: Ali, A. A. M., et al.
Publicado: (2011)

Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea
por: Yoo, Wan-Hee, et al.
Publicado: (2021)

Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
por: Hiraishi, Itaru, et al.
Publicado: (2021)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
por: Hedley, Adam J., et al.
Publicado: (2008)

Sirolimus-induced interstitial pneumonitis in a renal transplant recipient
por: Kanaan, Nada, et al.
Publicado: (2008)

Time-Varying Risk Factors for Incident Fractures in Kidney Transplant Recipients: A Nationwide Cohort Study in South Korea
por: Eum, Sang Hun, et al.
Publicado: (2023)

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
por: Kim, Hyeongyeong, et al.
Publicado: (2021)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Development of predictive score for post-transplant survival based on pre-transplant recipient characteristics
por: Koo, Tai Yeon, et al.
Publicado: (2021)

Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017–2021)
por: Eun, Byung-Wook, et al.
Publicado: (2023)

COVID-19 among solid organ transplant recipients in Korea: surveillance data of the Korean Transplantation Society, January 2020 to March 2022
por: Kang, Ji-Man, et al.
Publicado: (2022)

Sirolimus-Induced Rash in a Kidney Transplant Patient
por: Bruss, Zachary, et al.
Publicado: (2022)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
por: Ahn, Seo-Yeon, et al.
Publicado: (2022)

Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients
por: Jeon, Ja Young, et al.
Publicado: (2023)

Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature
por: Einollahi, Behzad, et al.
Publicado: (2014)

Effect of sirolimus on carotid atherosclerosis in kidney transplant recipients: data derived from a prospective randomized controlled trial
por: Silva, Andre L, et al.
Publicado: (2018)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Cardiovascular Diseases after Kidney Transplantation in Korea
por: Jeong, Jong Cheol, et al.
Publicado: (2010)

Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
por: Yoo, Wan-Hee, et al.
Publicado: (2022)

The effect of ABCB1 polymorphism on sirolimus in renal transplant recipients: a meta-analysis
por: Shao, Shuai, et al.
Publicado: (2020)

Sirolimus in a Renal Transplant Recipient Infected With COVID-19: A Blessing in Disguise?
por: Talwar, Dhruv, et al.
Publicado: (2021)

Characteristics of kidney transplantation recipients over time in South Korea
por: Park, Sehoon, et al.
Publicado: (2020)

Epidemiology, risk factors, and clinical impact of early post-transplant infection in older kidney transplant recipients: the Korean organ transplantation registry study
por: Kim, Jin Sug, et al.
Publicado: (2020)

Post-marketing safety surveillance of the rotavirus vaccine in India
por: Kang, Gagandeep, et al.
Publicado: (2023)

Competitive Market Analysis of Transplant Centers and Discrepancy of Wait-Listing of Recipients for Kidney Transplantation
por: Cho, P. S., et al.
Publicado: (2015)

Impact of iron status on kidney outcomes in kidney transplant recipients
por: Kim, Hyo Jeong, et al.
Publicado: (2023)

Evaluation of Nutrient Intake in Early Post Kidney Transplant Recipients
por: Rho, Mi Ra, et al.
Publicado: (2013)

Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
por: Lee, Ji Yeon, et al.
Publicado: (2023)

Management and prevention of post-transplant malignancies in kidney transplant recipients
por: Stallone, Giovanni, et al.
Publicado: (2015)

Safety and efficacy of fimasartan with essential hypertension patients in real world clinical practice: data from a post marketing surveillance in Korea
por: Han, Su-Eun, et al.
Publicado: (2018)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_trsma400gi6u884jvbp4kkq21b